Company news
Sana Biotechnology, Inc. news in 2022
Sana Biotechnology, Inc.'s news releases, calls and decks from 2022, newest first.
Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual Meeting
December 10, 2022
Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio Prioritization
November 28, 2022
Sana Biotechnology Tops BioSpace’s 2023 Best Places to Work Ranking in Small Employer Category
November 13, 2022
Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th American Society of Hematology Annual Meeting
November 2, 2022
Sana Biotechnology Reports Third Quarter 2022 Financial Results and Business Updates
November 1, 2022
Sana Biotechnology to Present at September 2022 Investor Conferences
September 8, 2022
Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business Updates
August 3, 2022
Sana Biotechnology Presents Data at ISSCR 2022 Annual Meeting Showing Survival of Transplanted Hypoimmune iPSC-Derived Differentiated Cell Types Without Immunosuppression in Non-Human Primates
June 16, 2022
Sana Biotechnology Announces Multiple Preclinical Data Presentations to Showcase Its Hypoimmune Platform, Including in Type 1 Diabetes, at the Upcoming ISSCR 2022 Annual Meeting
June 12, 2022
Sana Biotechnology to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
June 6, 2022
Sana Biotechnology Announces Plan to Relocate Manufacturing to Bothell, Washington Along with Key Executive Hires in Manufacturing and Regulatory
May 31, 2022
Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute
May 11, 2022
Sana Biotechnology Reports First Quarter 2022 Financial Results and Business Updates
May 9, 2022
Sana Biotechnology to Present at the BofA Securities 2022 Healthcare Conference
May 3, 2022
Sana Biotechnology to Present Data from Multiple Preclinical Studies at the American Society of Gene and Cell Therapy 25th Annual Meeting
May 1, 2022
Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates
March 15, 2022
Sana Biotechnology to Present at the 32nd Annual Oppenheimer Healthcare Conference
March 8, 2022
Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting
March 7, 2022
Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct
January 10, 2022
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
January 9, 2022
Sana Biotechnology to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 3, 2022
Decks in 2022
- Investor Presentation (June 2022)
Investor deck · 30 slides · Jun 14, 2022
- Investor Presentation (January 2022)
Investor deck · 28 slides · Jan 11, 2022